JESSICA FUQUA: Open Payments
NPI 1659981959 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 4 companies in 2025. Trend: 2023 $1,097 · 2024 $521 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $130 |
| TerSera Therapeutics LLC | 1 | $32 |
| ABBVIE INC. | 1 | $28 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
Products named: Fabhalta, Zoladex, IMBRUVICA, SCEMBLIX, QINLOCK.
Industry payments across AL — which companies pay providers there.
